organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Epidemiology: ºÚÁÏÍø have been cited by esteemed scholars and scientists all around the world. Epidemiology: ºÚÁÏÍø has got h-index 22, which means every article in Epidemiology: ºÚÁÏÍø has got 22 average citations.
Following are the list of articles that have cited the articles published in Epidemiology: ºÚÁÏÍø.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|
Total published articles |
40 | 50 | 61 | 62 | 31 | 20 | 29 | 51 | 66 |
Research, Review articles and Editorials |
17 | 40 | 36 | 15 | 17 | 12 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
0 | 2 | 7 | 16 | 2 | 0 | 0 | 0 | 0 |
Conference proceedings |
0 | 5 | 0 | 0 | 0 | 0 | 47 | 64 | 61 |
Citations received as per Google Scholar, other indexing platforms and portals |
413 | 486 | 526 | 526 | 480 | 428 | 271 | 226 | 181 |
Journal total citations count | 3849 |
Journal impact factor | 10.58 |
Journal 5 years impact factor | 10.09 |
Journal cite score | 10.22 |
Journal h-index | 22 |
Journal h-index since 2019 | 18 |
Evaluating the effectiveness of risk minimisation measures: the application of a conceptual framework to Danish real-world dabigatran data |
|
| | | |
A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU |
|
| | | |
The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products |
|
| | | |
Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder |
|
| | | |
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs |
|
| | | |
Additional risk minimisation measures in the EU– are they eligible for assessment |
|
| | | |
Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and Preferences |
|
| | | |
The Effectiveness of an Educational Brochure as a Risk Minimization Activity to Communicate Important Rare Adverse Events to Health-Care Professionals |
|
| | | |
Methodological gaps in the assessment of risk minimization interventions: a systematic review |
|
| | | |
Advancing the Field of Pharmaceutical Risk Minimization Through Application of Implementation Science Best Practices |
|
| | | |
Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee |
|
| | | |
Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works |
|
| | | |
Association of a 62 Variants Type 2 Diabetes Genetic Risk Score With Markers of Subclinical Atherosclerosis |
|
| | | |
Late Stage Complications of Diabetes and Insulin Resistance |
|
| | | |
The aetiology of vaginal symptoms in rural Haiti |
|
| | | |
Malaria elimination in Haiti by the year 2020: an achievable goal? |
|
| | | |
Prevalence of Obesity among Adult Surgical Patients in Tobago |
|
| | | |
Exploring the role of obesity and overweight in predicting postoperative outcome of abdominal surgery in a sub-Saharan African setting: a prospective cohort study |
|
| | | |
Coffea arabica: Herbal drug on Global health issue-obesity |
|
| | | |
Prevalence of Obesity Among Thi-Qar University Students During the Year 2015- 2016 |
|
| | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, ºÚÁÏÍø Journals